Author
Duane E. DeMong
Also Known As
Duane DeMong, Duane E DeMong, Duane E. DeMong, Duane E. Demong*
31
Publications
1K
Citations
13
H-Index
22
Concepts
All Affiliations
| # | Concept | H-Index | Publications | Citations |
|---|---|---|---|---|
1 | Medicine | 6 | 6 | 217 |
2 | Natural Sciences | 5 | 5 | 139 |
3 | Biochemistry | 5 | 5 | 133 |
4 | Engineering | 2 | 2 | 65 |
5 | Biomolecular Engineering | 2 | 2 | 65 |
Duane E. DeMong
×
15
Publications
978
Citations
12
H-Index
| Year | Citations | |
|---|---|---|
2015 | 326 | |
1998 | 221 | |
Discovery of a 3-(4-Pyrimidinyl) Indazole (MLi-2), an Orally Available and Selective Leucine-Rich Repeat Kinase 2 (LRRK2) Inhibitor that Reduces Brain Kinase Activity Jack D. Scott, Duane E. DeMong, Thomas J. Greshock, Journal of Medicinal Chemistry Drug TargetPharmacotherapyMedicinal ChemistryBrain Kinase ActivityLrrk2 Inhibitors | 2017 | 140 |
2003 | 71 | |
2022 | 53 | |
2001 | 33 | |
2007 | 25 | |
2022 | 19 | |
2008 | 16 | |
2001 | 16 |
Page 1
Page 1